David Rosen – TEVA history
- Issuer:
- TEVA PHARMACEUTICAL INDS LTD
- Quarters tracked:
- 14 (Q1 2023 → Q2 2026)
- Current shares:
- 15,575,000
- Current value:
- $527.68M
- Peak shares:
- 26,000,000 (Q2 2025)
- Overall change:
- +246%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q2 2026 | 15,575,000 | $527.68M | $33.88 | +325,000 | +2% |
| Q1 2026 | 15,250,000 | $459.33M | $30.12 | -6,105,510 | -29% |
| Q4 2025 | 21,355,510 | $666.50M | $31.21 | -3,294,490 | -13% |
| Q3 2025 | 24,650,000 | $497.93M | $20.20 | -1,350,000 | -5% |
| Q2 2025 | 26,000,000 | $435.76M | $16.76 | +450,000 | +2% |
| Q1 2025 | 25,550,000 | $392.70M | $15.37 | +8,550,000 | +50% |
| Q4 2024 | 17,000,000 | $374.68M | $22.04 | +994,502 | +6% |
| Q3 2024 | 16,005,498 | $288.42M | $18.02 | -1,256,243 | -7% |
| Q2 2024 | 17,261,741 | $280.50M | $16.25 | -407,847 | -2% |
| Q1 2024 | 17,669,588 | $249.32M | $14.11 | -557,013 | -3% |
| Q4 2023 | 18,226,601 | $190.29M | $10.44 | -773,399 | -4% |
| Q3 2023 | 19,000,000 | $193.80M | $10.20 | +281,638 | +2% |
| Q2 2023 | 18,718,362 | $140.95M | $7.53 | +14,218,556 | +316% |
| Q1 2023 | 4,499,806 | $39.82M | $8.85 | — | NEW |